Posted on April 20th, 2012, 3:53 pm
MedPage Today By Chris Kaiser, Cardiology Editor, MedPage Today WASHINGTON -- The FDA warned Friday against combining the blood pressure medication aliskiren (Tekturna) with ACE inhibitors and angiotensin receptor blockers (ARBS) in patients with diabetes or renal ... |